Other languages Ventripoint Diagnostics Ltd.

Equities

VPT

CA92281P2008

Delayed Toronto S.E. Other stock markets 12:17:09 2024-05-10 pm EDT			5-day change	1st Jan Change
0.25 ^CAD	+2.04%		0.00%	-15.25%

Apr. 30	Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 11	VentriPoint Diagnostics Ltd. announced that it expects to receive CAD 3 million in funding	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ventripoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29
Ventripoint Diagnostics Ltd. Releases Significant Upgrade to the Design and Function of Its Whole-Heart Analysis System (VMS+3.2)	Mar. 04
Ventripoint Diagnostics Ltd. Showcases A.I. Powered Heart-Scanning Technology at International Cardiology Conferences	Feb. 20
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as Interim CEO	Feb. 05
Ventripoint Diagnostics Ltd. Appoints Hugh Macnaught as President	Feb. 05
The Paediatric Heart Centre At the Medical University of Vienna Has Chosen to Adopt the Vms+ as Its Cardiac Diagnostic Tool	Feb. 01
VentriPoint Diagnostics Ltd. Announces Appointment of Dr. Luc Mertens to Clinical Advisory Board	Jan. 20
VentriPoint Diagnostics Ltd. Enters into A Global Distribution and Marketing Agreement with Ascend Cardiovascular	Dec. 12
VentriPoint Diagnostics Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 29
VentriPoint Diagnostics Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-28
Ventripoint Welcomes Evelina London Children's Hospital as Newest Vms+ User	23-08-22
Ventripoint Diagnostics Ltd. Announces That Ventripoint and Ascend Cardiovascular, Llc Have Developed A New Integrated Product	23-08-18
Ventripoint Diagnostics Ltd. Announces Collaboration with Ascend Cardiovascular	23-08-10
VentriPoint Diagnostics Ltd. Announces Purchase of VMS+ by Medical Center University of Freiburg	23-07-18
VentriPoint Diagnostics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-30
VentriPoint Diagnostics Ltd. Auditor Raises 'Going Concern' Doubt	23-04-30
VentriPoint Diagnostics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-30
Ventripoint Diagnostics Ltd. Announces Appointment of Alvira Macanovic as President	23-01-03
Ventripoint Diagnostics Ltd Announces Appointment of Alvira Macanovic as CEO	23-01-03
Ventripoint Signs on Arc Group Medical LLC as Distributor in Florida Region	22-11-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Ventripoint Diagnostics Ltd.

Equities

VPT

CA92281P2008

Other languages

Filters